Nicotinic acid adenine dinucleotide phosphate sodium salt
SIGMA/N5655 - ≥92.5%
Synonym: β-NAADP
CAS Number: 5502-96-5
Empirical Formula (Hill Notation): C21H27N6O18P3 · xNa+
Molecular Weight: 744.39 (free acid basis)
MDL Number: MFCD00274064
Linear Formula: C21H27N6O18P3 · xNa+
Product Type: Chemical
| assay | ≥92.5% |
| form | solid |
| InChI | 1S/C21H27N6O18P3.Na/c22-1 |
| InChI key | KKCRODBDXQTAPI-NZNNTXIPSA |
| Quality Level | 200 ![]() |
| SMILES string | [Na+].Nc1ncnc2n(cnc12)[C@ |
| storage temp. | −20°C |
| Application: | Nicotinic acid adenine dinucleotide phosphate sodium salt has been used for agonist injection into unfertilized eggs and embryos. |
| Biochem/physiol Actions: | Potent activator of intracellular Ca2+ release via an IP3 and cyclic ADP ribose-independent mechanism. |
| General description: | NAADP induces Ca2+ release from the eggs of sea urchin, when injected into the cell. It can be enzymatically produced from nicotinamide adenine dinucleotide phosphate (β-NADP) with the help of ADP-ribosyl cyclase. |
| Other Notes: | Note: Should not be confused with nicotinamide adenine dinucleotide phosphate (NADP). |
| Packaging: | 10, 25 mg in poly bottle |
| Preparation Note: | Enzymatically prepared analog of β-NADP+. |
| Symbol | GHS07 |
| Signal word | Warning |
| Hazard statements | H315 - H319 - H335 |
| Precautionary statements | P302 + P352 - P305 + P351 + P338 |
| Hazard Codes | Xi |
| Risk Statements | 36/37/38 |
| Safety Statements | 26-36 |
| RIDADR | NONH for all modes of transport |
| WGK Germany | WGK 3 |
| Purity | ≥92.5% |
| Storage Temp. | −20°C |
| UNSPSC | 12352106 |


